Clinical trial
The Impact of Caffeine on Cognition in Schizophrenia
NCT02832401
Study timeline
Study start (actual)2016-09-02Date precision: day
Registry last updated2022-11-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Caffeineunresolved
Interventions
CaffeineDRUG · verified · RxNorm: caffeine
PlaceboDRUG
Sponsors & collaborators
Nova Scotia Health Authoritylead sponsor
Dalhousie Universitycollaborator
Mount Saint Vincent Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02832401 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.